Covered recipient · General Payments record
PAMELA G GILLEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,644.38
- Reported across 162 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $394.13 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $159.73 | 14 |
| Amgen Inc. | $59.70 | 4 |
| Novo Nordisk AS | $58.59 | 3 |
| Acerta Pharma LLC | $52.79 | 3 |
| Lilly USA, LLC | $45.06 | 3 |
| Exact Sciences Corporation | $18.26 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $5.17 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619108 | CMS |
| ABBVIE INC. | $10.38 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619110 | CMS |
| ABBVIE INC. | $2.96 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619112 | CMS |
| ABBVIE INC. | $10.26 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619114 | CMS |
| ABBVIE INC. | $9.99 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619116 | CMS |
| ABBVIE INC. | $17.35 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619118 | CMS |
| ABBVIE INC. | $15.46 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619120 | CMS |
| ABBVIE INC. | $15.70 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619122 | CMS |
| ABBVIE INC. | $16.98 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619124 | CMS |
| ABBVIE INC. | $11.18 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619126 | CMS |
| ABBVIE INC. | $3.29 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619128 | CMS |
| ABBVIE INC. | $3.38 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619130 | CMS |
| ABBVIE INC. | $17.14 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619132 | CMS |
| ABBVIE INC. | $20.49 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103619134 | CMS |
| Amgen Inc. | $14.28 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538920 | CMS |
| Amgen Inc. | $15.42 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538922 | CMS |
| Amgen Inc. | $15.51 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538924 | CMS |
| Amgen Inc. | $14.49 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117538926 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.36 | 02/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105291404 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.84 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104434385 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.59 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104409225 | CMS |
| Exact Sciences Corporation | $18.26 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114631579 | CMS |
| Lilly USA, LLC | $18.10 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135304350 | CMS |
| Lilly USA, LLC | $13.45 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135182973 | CMS |
| Lilly USA, LLC | $13.51 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135304746 | CMS |
| Novo Nordisk Inc | $22.81 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096909305 | CMS |
| Novo Nordisk Inc | $16.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097503006 | CMS |
| Novo Nordisk Inc | $19.72 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097117944 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.